Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

PHASE3CompletedINTERVENTIONAL
Enrollment

582

Participants

Timeline

Start Date

May 3, 2017

Primary Completion Date

July 9, 2021

Study Completion Date

September 6, 2021

Conditions
Prevention of Venous Thromboembolism
Interventions
DRUG

Rivaroxaban

Tablets

DRUG

Placebo

Tablets

Trial Locations (17)

Unknown

Ospedale Santa Maria delle Grazie, Pozzuoli

Ospedale di Cittadella, Cittadella

Ospedale San Matteo degli Infermi, Spoleto

Ospedale E. Agnelli, Pinerolo

Ospedale San Giacomo Apostolo, Castelfranco Veneto

Istituto Clinico Humanitas Mater Domini, Castellanza

Ospedale San Donato, Arezzo

AOU Careggi, Florence

"Nuovo Ospedale San Giovanni Battista", Foligno

AOU Federico II, Napoli

IRCCS Fondazione Pascale, Napoli

Policlinico di Padova, Padua

Ospedale Santa Maria della Misericordia, Perugia

Ospedale San Salvatore, Pesaro

Ospedale di Piacenza, Piacenza

Policlinico Gemelli, Roma

Ospedale Santa Maria, Terni

All Listed Sponsors
collaborator

University Of Perugia

OTHER

lead

Fadoi Foundation, Italy

OTHER

NCT03055026 - Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. | Biotech Hunter | Biotech Hunter